Synthesis of Canthardin Sulfanilamides and Their Acid Anhydride Analogues via a Ring-Opening Reaction of Activated Aziridines and Their Associated Pharmacological Effects
Abstract:Abstract:The cantharidinimide derivatives, 5a-h, including sulfanilamides containing pyrimidyl, pyrazinyl, hydrogen, thiazolyl, and oxazolyl groups were synthesized.Modification of cantharidinimide by means of the reaction of activated aziridine ring opening led to the discovery of a novel class of antitumor compounds. The analogues 10i-k, 11l-n, 12o-p, and 16q-s were obtained from treating cantharidinimide 6 and analogues (7, 8, and 13) with activated aziridines, which produced a series of ring-opened product… Show more
“…In the event, a treatment of the bis-mesylate with K-phthalimide in dimethylformamide (DMF) at ambient temperature smoothly afforded a single product (>90% yield) from this reaction, which was found to be the desired azetidine 39 with all-cis stereochemistry (Scheme 5). 16 The isolation of 39 as a crystalline solid could be induced by a direct addition of water to the reaction mixture. The crystallinity of 39 provided a key quality control point at this juncture of the synthesis.…”
The
development of an entirely crystallization-based synthetic
route to the antimalarial BRD5018 is described, which assembles a
structurally complex bicyclic azetidine scaffold adorned with five
stereogenic centers without the need for any chromatographic separations.
A diastereoselective glycine ester Claisen rearrangement, diastereomeric
salt resolution, and diastereoselective iodo-lactonization are utilized
to provide an efficient access to three contiguous stereogenic centers
on an acyclic template with the desired relative and absolute configurations.
A tandem aziridine ring-opening/azetidine ring-closure on the derived
2-amino-1,4-diol template was developed to efficiently establish the
all-cis trisubstituted azetidine scaffold with the
proper ancillary functionality for end-game maneuvers. d-Ribose-2,3-acetonide
provided a conveniently differentiated vicinal syn-diol suitable for the planned reductive amination/periodate cleavage/Staudinger-aza-Wittig
sequence to form the eight-membered diazocene ring. An early quantitative
installation of the diaryl acetylene moiety via a Sonogashira coupling
on an electronically matched methyl 4-bromocinnamate circumvented
a low-yielding, late-stage reaction in the first-generation synthesis.
Multiple crystalline intermediates enabled the complete removal of
chromatography from the synthesis resulting in a substantially reduced
cost and waste generation with enhanced throughput and quality control.
“…In the event, a treatment of the bis-mesylate with K-phthalimide in dimethylformamide (DMF) at ambient temperature smoothly afforded a single product (>90% yield) from this reaction, which was found to be the desired azetidine 39 with all-cis stereochemistry (Scheme 5). 16 The isolation of 39 as a crystalline solid could be induced by a direct addition of water to the reaction mixture. The crystallinity of 39 provided a key quality control point at this juncture of the synthesis.…”
The
development of an entirely crystallization-based synthetic
route to the antimalarial BRD5018 is described, which assembles a
structurally complex bicyclic azetidine scaffold adorned with five
stereogenic centers without the need for any chromatographic separations.
A diastereoselective glycine ester Claisen rearrangement, diastereomeric
salt resolution, and diastereoselective iodo-lactonization are utilized
to provide an efficient access to three contiguous stereogenic centers
on an acyclic template with the desired relative and absolute configurations.
A tandem aziridine ring-opening/azetidine ring-closure on the derived
2-amino-1,4-diol template was developed to efficiently establish the
all-cis trisubstituted azetidine scaffold with the
proper ancillary functionality for end-game maneuvers. d-Ribose-2,3-acetonide
provided a conveniently differentiated vicinal syn-diol suitable for the planned reductive amination/periodate cleavage/Staudinger-aza-Wittig
sequence to form the eight-membered diazocene ring. An early quantitative
installation of the diaryl acetylene moiety via a Sonogashira coupling
on an electronically matched methyl 4-bromocinnamate circumvented
a low-yielding, late-stage reaction in the first-generation synthesis.
Multiple crystalline intermediates enabled the complete removal of
chromatography from the synthesis resulting in a substantially reduced
cost and waste generation with enhanced throughput and quality control.
“…Other relevant derivatives are the cantharidin-sulfanil-Figure 9. Norcantharidin , cantharidin [119][120][121][122][123][124][125][126][127][128][129][130][131], and related molecules.…”
Section: Oxanorbornene Derivativesmentioning
confidence: 99%
“…The new designed analogue methyl cantharidimide (Figure 9, 9i) was effective against endocervical adenocarcinoma cell line KB-C2 overexpressing ABCB1 and against human SDHB knockout HEK-293 cell line, which overexpresses ABCG2, as well as cisplatin-resistant cells, such as KCB-4 [128]. Other relevant derivatives are the cantharidin-sulfanilamides (Figure 9, 9j) that exhibited anti-HL-60 and anti-Hep3B cell activities [129].…”
The norbornene scaffold has arisen as a promising structure in medicinal chemistry due to its possible therapeutic application in cancer treatment. The development of norbornene-based derivatives as potential chemotherapeutic agents is attracting significant attention. Here, we report an unprecedented review on the recent advances of investigations into the antitumoral efficacy of different compounds, including the abovementioned bicyclic scaffold in their structure, in combination with chemotherapeutic agents or forming metal complexes. The impact that structural modifications to these bicyclic compounds have on the antitumoral properties and the mechanisms by which these norbornene derivatives act are discussed in this review. In addition, the use of norbornene, and its related compounds, encapsulation in nanosystems for its use in cancer therapies is here detailed.
“…In the article “Synthesis of Canthardin Sulfanilamides and Their Acid Anhydride Analogues via a Ring-Opening Reaction of Activated Aziridines and Their Associated Pharmacological Effects” [ 26 ], Mei-Hsiang Lin and coworkers reported their investigation to find new cantharidinimides and related imides containing the sulfonamide group. The modification of cantharidinimide by means of the reaction of activated aziridine ring opening led to the discovery of a novel class of antitumor compounds.…”
mentioning
confidence: 99%
“…They found that the most potent cytostatic compound, N -cantharidinimido-sulfamethazine, exhibited anti-HL-60 and anti-Hep3B cell activities. Detailed results of their investigation are presented in the article [ 26 ].…”
Drug discovery is the process through which potential new therapeutic entities are identified, using a combination of computational, experimental, translational, and clinical models (see, e.g., [1,2]).[...]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.